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INTRODUCTION
Cancers have been the greatest death cause in Ja-
pan since 1981. In 2008, they accounted for 340,000
of the total death number of 1.14 millions, reach-
ing 30.0% of this total number (1). The history of
the actions against cancers in Japan started from
the establishment of a NPO “Japanese Foundation
for Cancer Research” in 1908 with the aim of “Con-
tributing the welfare of humankind by eradicating
cancers” (2). In August 1958, proposed by Japanese
Cancer Association, the Japan Cancer Society was
established (3). In 1962, as a national policy, the Na-
tional Cancer Center was established to play a core
role in actions against cancers (4).
In every 10 years, the government sets out plans
such as “Comprehensive 10-year Strategy for Can-
cer Control” operative since 1984 and “New 10-year
Strategy to Overcome Cancer” since 1994. Since
2004, it has advanced “The 3rd-term Comprehen-
sive 10-year Strategy for Cancer Control” (until
2013) containing the objectives of “Promotion of
cancer prevention” and “Improvement of cancer
treatment and of social environment to support this
goal” as pillars. This aims to promote cancer re-
search and to disseminate high quality cancer medi-
cal services with the slogan “Drastic reduction in
cancer morbidity and mortality”.
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As shown, measures against cancers have been
gradually put into effect. Subsequently, for the sake
of early detection of cancer, the Cancer Control Act
2007 was enacted to aim the screening rate of 50%
within 5 years, and the implementation of accu-
racy management and project evaluation in all the
municipalities. Additionally, the Ministry of Health,
Labour and Welfare (MHLW) set “the Headquarters
of 50% Cancer Screening Rate” in 2009, showing
its serious actions towards improvement in cancer
screening rate (5).
Precedent studies on stomach cancer screening
in Japan include a report suggesting that improv-
ing trends in the survival rate can be explained by
early cancer detection although the effectiveness of
screening is not proved yet (6, 7). From guidelines
available in Japan (8, 9), as methods using photo-
fluorography are recommended in population-based
screening and opportunistic screening, early detec-
tion by and contents of screening are important.
Evidence for preventive measures to reduce the
cancer mortality rate is available only in the aspect
of the actions against smoking and some other can-
cer screenings (10). Cancer screening is considered
to be very effective in reducing the cancer mortal-
ity rate as it enables cancer detection at an early
stage of cancer development. Today, the following
screenings are considered to be effective based on
medical evidence : stomach cancer screening ; lung
cancer screening ; colorectal cancer screening ;
uterus cancer screening ; and breast cancer screen-
ing (8, 9, 11). Thus, in this paper, the five men-
tioned cancer screenings are the subjects in order
to examine the relation between the screening rate
and the mortality rate on the basis of currently avail-
able information.
MATERIALS AND METHODS
The data on the screening rates and mortality
rates were collected from databases and publications
of the MHLW, the Center for Cancer Control and
Information Services, the National Cancer Center,
and the Cabinet Office (5, 12-15). In Japan, although
the screening for uterus cancer targets those over
20 years old, the screenings for stomach cancer,
lung cancer, colorectal cancer, and breast cancer
target those over 40. Hence, age groups over 40
were the subjects in this analysis.
On the screening rates, each of the cancer screen-
ings started at a different period of time from each
other. As there had possibly existed no established
screening system at an early period, data from last
15 years (between 1993 and 2007) were analyzed.
Also, as not all gender data on the screening rates
were publicly open, the calculation of the rates was
based on the values which were figured out from
inferred screening rates according to gender from
the gender ratios in the screening rates in 2007.
On the mortality rates, the data from 1958 to
2008, and the crude mortality rates in the popula-
tion of 100,000 (the number of cancer death divided
by the population of the subject group) were used.
The mortality rate for uterus cancer in women aged
20 or over, and the mortality rate for breast cancer
in women aged 40 or over were re-calculated.
The classification based on the International Clas-
sification Diseases codes (ICD) was applied to the
subject sites. The classification conformed to ICD-
7 for the data between 1958 and 1967, ICD-8 be-
tween 1968 and 1976, ICD-9 between 1977 and
1994, and ICD-10 between 1995 and 2008. For
stomach, code 151 (ICD-7, 8, 9) or code C16 (ICD-
10) was used. For lung, code 162-163 (ICD-7), code
162 (ICD-8, 9), or code C33-34 (ICD-10) was/were
used. For colon, code 153-154 (ICD-7, 8, 9) or code
C18-21 (ICD-10) were used ; for breast, code 170
(ICD-7), code 174 (ICD-7, 8), code 174-175, 233.0
(ICD-9), or code C50 D05 (ICD-10) was/were used.
For uterus, code 171 - 174 (ICD-7), code 180 - 182
(ICD-8), code 179-182 (ICD-9), or code C53-C55
(ICD-10) were used.
The relation between the mortality rate and the
screening rate was examined by referring to the
national level of the rates and the level according
to administrative divisions. Data were used to ana-
lyze the national level in 15 years. However, because
the cancer screening rate according to administra-
tive divisions was published only until 2007, the
screening rates and age-adjusted cancer death rates
in 2007 were used in the analysis regarding admin-
istrative divisions. Linear regression analysis and
regression coefficients were calculated in order to
examine the relations between these variables. The
statistics software of SPSS ver.16.0J (SPSS inc.
Tokyo, Japan) was used.
RESULTS
1. Cancer screening rate
According to the report on regional health and eld-
erly-health projects prepared in 2007, the screening
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rates were : 11.8% for stomach cancer ; 18.8% for
colorectal cancer ; 18.8% for uterus cancer ; and
14.2% for breast cancer. Even the highest screening
rate of lung cancer managed to reach only 21.6%.
The screening rate for stomach cancer gradually de-
clined, and the variation rate was about 3% in both
sexes. The screening rate for lung cancer has de-
clined in the last 4 years with the variation rate of
about 4%. The screening rate for colorectal cancer
has increased year by year with an annual in-
crease rate of about 0.5%. Its variation has been as
great as about 8%. The screening rate for uterus can-
cer experienced a declining trend from 1991, but it
has increased 1.3 times higher in the last 3 years.
The screening rate for breast cancer had a rapid
increase in 2005, and has had an increasing trend
overall (Figure 1).
On an international standard, Japan is at the low-
est level among the 30 member countries of Organi-
zation for Economic Co-operation and Development
(OECD), in comparison with the Western countries
where the screening rates for breast cancer and
uterus cancer are over 70%, (Table 1) (16, 17).
2. Cancer mortality rate
The mortality rate for stomach cancer showed an
increasing trend until around 1970s, but from then
it showed a declining trend in the subsequent years.
This variation approximated a value of 10. Accord-
ing to gender, a declining tread was observed in
women after 1970, while no change was observed
in men after 1990, and the male mortality rate was
1.5 times greater than the female one. The mortality
rate for stomach cancer in those aged 40 or over be-
tween 1970 and 1990 decreased year by year by the
average of 3.7 people in men (p0.001) and the aver-
age of 2.2 people in women (p0.001) (Figure 2A).
According to age groups, the higher age groups had
a higher mortality rate both in women and men.
The mortality rate for lung cancer increased sig-
nificantly year by year both in women and men, and
its increase rate was the greatest compared with
the other 4 cancers in all the years. Both in women
and men, it increased 10 times higher in the last
50 years. Moreover, the increase in the mortality
rate was significant for both women and men aged
40 or over : an increase of 2.5 people in one year
for men (p0.001) and an increase of 0.8 people
for women (p0.001). The variation value in the
mortality rate was : about 30 in men and about 20
in women, which showed a greater variation com-
pared with that in the other cancers (Figure 2B).
In the last 20 years, despite a declining trend in
men aged over 65 or over, the mortality rates for
both men and women tended to be higher as their
ages were higher.
The mortality rate for colorectal cancer in both
sexes increased a lot year by year in all the years.
The variation value of the rate was about 15. In the
last 50 years, there were an about 7 times increase
in men and an about 6 times increase in women.Figure 1. Trends in cancer screening rate
Table 1. Screening rate (%) of cervical and breast cancer
Cervical cancer screening of women aged 20-69 Mammography screening of women aged 50-69
2000 2003 2006 2000 2003 2006
Japan 22.6 23.7 24.5 22.5 23.3 23.8
United States 85.7 83.9 83.5 77.8 76.0 72.5
United Kingdom 83.4 81.2 79.4 69.8 74.7 70.7
Norway 70.3 72.5 75.6 79.2 75.6 76.7
Average of 30 countries
in OECD 62.3 63.8 64.0 58.3 61.6 62.2
OECD iLibrary, Health at a glance 2009 : OECD indicators, 2009 (16, 17)
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In the last 20 years, the mortality rate for men was
1.2 times higher than that for women. For those
aged 40 or over, the mortality rate increased in both
sexes : a 1.3 people increase in men in one year (p
0.001) and 0.8 people increase in women (p0.001)
(Figure 2C). According to age groups, although the
Figure 2. Trends in cancer mortality rate
shows men and women aged 40 or over
shows men aged 40 or over
shows women aged 40 or over
shows women aged 20 or over
shows all men and women
shows all men
shows all women
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mortality rate became higher as the ages became
higher, there was a declining trend in the rate for
both sexes aged 55 years old or over in the last 10
years. This trend was more apparent in men than
in women.
The mortality rate for uterus cancer declined until
about 1990 but then tended to increase in the sub-
sequent years. The rate was half as much as the
rate 50 years ago. For those aged 20 years old or
over, there was a 0.5 people decline in one year
until about 1990 (p0.001) but then a small annual
increase of 0.08 people was observed (p0.001)
(Figure 2D).
The mortality rate for breast cancer has an in-
creasing trend in all the years. For those aged 40
years old or over, there was an annual increase of
0.3 people in the period of 1970 to 1990 (p0.001),
and then the increase rate became higher by 0.7
people (p0.001) (Figure 2E). According to age
groups, there was an increasing trend in those aged
50 or over. Those aged younger than 50 have had
a declining trend since 10 years ago (Figure 3).
3. Relation between the cancer screening rate and
the cancer mortality rate
The relations between each screening rate for
stomach cancer, lung cancer, colorectal cancer,
uterus cancer, breast cancer and their respective
mortality rate were illustrated in Table 2. In stomach
and colorectal cancers, there was a positive corre-
lation between their screening rate and mortality
rate (p0.001). Especially in colorectal cancer, a
positive correlation was observed in both sexes (p
0.001). There was no significant statistical relation-
ship between the screening rate for lung cancer
and its mortality rate. There was no clear relation
found between the screening rates for breast and
uterus cancers and their mortality rates.
4. Relation between cancer mortality rate and can-
cer screening rate in administrative divisions
The screening rate for stomach cancer was 19%
to 50%, and differed greatly among regions. The
national average of the rate was 27% and 34% for
women and men respectively, and the male rate was
significantly higher than the female one (p0.001).
The mortality rate of stomach cancer was 7% and
18% for women and men respectively. The relation
between the screening rate and the mortality rate
of stomach cancer was not significant (Figure 4A).
The screening rate of lung cancer had twice or
more a regional difference, and it was 14% to 37%.
The national average of the screening rate was 23%
and 27% for women and men respectively, and the
value was lower than the stomach cancer screening
rate. In relations with the screening and the mor-
tality rate of lung cancer, the mortality rate signifi-
cantly decreased as the screening rate improved
(p0.005). In other words, the mortality rate de-
creased by 0.12 when the screening rate improved
1% (p0.05). In the aspect of gender, the result had
a similar tendency (p0.05) (Figure 4B).
The screening rate of colorectal cancer was 16%
to 38%, and the regional difference was great. The
Table 2. Correlation between screening rate (%) and mortality rate for each cancer
Stomach cancer Lung cancer Colorectal cancer Uteruscancer
Breast
cancer
All Men Women All Men Women All Men Women Women Women
Correlation coefficient 0.833* 0.706 0.862* 0.643 0.652 0.621 0.992* 0.982* 0.991* 0.260 0.461
Regression slope 3.60* 3.11 3.34* 4.67 6.68 2.59 1.78* 1.80* 1.76* 0.06 0.885
* p0.001
Mortality rate is calculated as (Cancer Deaths/Population)100,000
The center for cancer control and information services, National cancer center (5)
Figure 3. Trends in breast cancer mortality rate by age-group
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national average of the screening rate was 23% and
28% for women and men respectively, and the re-
sult was similar to that of lung cancer (Figure 4C).
The screening rate of uterus cancer was 17%
to 31%, and the national average of the rate was
22%. The result had a similar trend to that of breast
cancer (Figure 4D).
The screening rate of breast cancer was 14% to
33%, and the national average of the rate was 21%.
The results were moderately low, compared with
stomach cancer, lung cancer and colorectal can-
cer (Figure 4E) (Table 3). A significant positive
Figure 4.
Relationship between the screen-
ing rate and the mortality rate for
cancer in prefectures
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correlation was found between the breast cancer
screening rate and the uterus cancer screening rate
(r=0.932, p0.001).
DISCUSSION
In the lung cancer screening cancer rate, we
found that the mortality rate decreased with the im-
provement in the cancer screening rate. This means
that cancer screening examination helps cancer
mortality decrease.
In this consideration of the relation between the
cancer screening rate and the mortality rate, the
important point to pay attention to was the result
that a statistically positive correlation was found in
the cases of colorectal cancer and stomach cancer
in women, and that the mortality rate increased as
the cancer screening rate was improved. However,
the result of this research was not a cohort study
but an observation of the correlations between the
cancer screening rate and the mortality rate in each
year. In this research, although the subject ages
were identified, the mortality rate was not calcu-
lated from the death number of the screening re-
cipients. Consequently, we treated the results as an
information material to analogize with problems in
cancer screening, and our consideration on is as
below.
For colorectal cancer, whose screening rate has
increased recently, the faecal occult blood test is
recognized worldwide as a method of screening
and as having an effect of decreasing the mortality
rate (18). However, in the screening situation of
colorectal cancer in Japan, problems such as the
inadequate implementation structure of workup have
been pointed out (19). Hence, we thought that the
screening of colorectal cancer has not achieved early
detection of it.
On lung cancer, there are reports from results
of cohort studies in Japan that the mortality rate
for screening recipients is lower than that for non-
recipients (20, 21). However, on the screening meth-
ods, chest radiography and sputum cytology have
only limited effect in decreasing the mortality rate.
Though the low-dose thoracic CT screening is rec-
ommended, its efficacy has not been reported as es-
tablished (22). Thus, the improvement in the accu-
racy of screening is considered to be an issue. Re-
duction in the mortality rate is a pressing issue with
lung cancer which requires to be solved through
the improvement in the accuracy of and in the rate
of screening as well as the promotion activities such
as advising on smoking.
On breast cancer, although its occurrence has in-
creased in European and North American coun-
tries, the mortality rate lowered (23, 24). On the
other hand, its occurrence and mortality rate has
increased year by year in Japan. It was considered
that no effective screening program against breast
cancer had been introduced (25).
The mammography screening rate is 70% to 80%
in the West, whereas in Japan it is only 12.4% of
the targeted women aged 40 or over (26). On this
matter, Japan is at the lowest level among the 30
member countries of OECD. Despite a high screen-
ing rate in Europe, the European Council recom-
mended the implementation of the screening for
breast and cervical cancers for women and the
screening for colorectal cancer for both women and
Table 3. Correlation between screening rate (%) and mortality rate for cancer in prefectures
Stomach cancer Lung cancer Colorectal cancer
All Men Women All Men Women All Men Women
Correlation
coefficient 0.201 0.241 0.084 0.424** 0.323* 0.361* 0.051 0.128 0.017
Regression
slope -0.08 0.15 -0.02 -0.12** -0.17* -0.06* -0.02 -0.06 0.005
Uterus cancer Breast cancer
Women Women
Correlation
coefficient 0.198 0.053
Regression slope -0.05 0.02
* p0.05, ** p0.005
mortality rate shows age-adjusted cancer death rate.
The center for cancer control and information services, National cancer center (5)
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men, thus further encouraging cancer screening
in the European Union (27). In the results of this
research, an increase in the mortality rate for breast
cancer was observed among the age groups aged
50 or over, but conversely there was a decline in
the younger age groups. From this, it is considered
necessary at least for women aged 50 or over to
undertake cancer screening routinely.
Next, though the mortality rate for uterus cancer
dropped until 1990, there has been an increasing
trend since then. As reasons for this, the increase
of cervical cancer among young people and the cur-
rent screening solely based on cytology are pointed
out (28). However, as organized screening is re-
ported to lead decline in the morbidity and mortal-
ity rate in the Nordic countries (29), clear effects
can be expected in organized screening targeting
a group. There is also a reported case in which the
screening for cervical cancer for those aged between
30 to 79 years old would decline the mortality rate
(21). In our research, the mortality rate for uterus
cancer, which showed a declining trend, has indi-
cated an increasing trend since 1990s though the
trend has been gradual. In the prevention of more
increase, measures to improve the screening rate
for young people are a high priority. Since 2009,
for the purpose of disseminating and promoting the
screening for female-specific cancers, early detec-
tion of cancer, and appropriate awareness of health,
a handbook for the screening for uterus and cervi-
cal cancers and coupons for free screening have
been distributed to women at a certain age. It is
hoped that this will help the screening rate rise close
to the one in Western countries in future (30).
From the view of screening recipients, their con-
cerns include those about the screening environ-
ment and screening methods. In fact, the screening
rates in urban areas are below the nationwide av-
erages (12, 31). On uterus cancer, which is female-
specific, factors such as the sense of shame are rec-
ognized as causing a decline in the screening rate.
Recently, the number of medical institutions for
women has increased as the demand for medical
treatment with gender consideration is high (32).
Thus, such institutions should be made full use of.
CONCLUSION
A statistical analysis was conducted on the can-
cer screening rate (between the year 1983 and
2007) and the cancer mortality rate (between 1958
and 2008) based on the information obtained from
databases and publications. As a result, in the lung
cancer screening cancer rate, we found that the
mortality rate decreased with the improvement of
the cancer screening rate. This means that cancer
screening examination helps mortality decrease.
Therefore, for lung cancer which has a high mor-
tality rate with an increasing trend, breast cancer
whose mortality rate continues to rise in people aged
50 or over, and uterus cancer whose mortality rate
used to have a declining trend but now has an in-
creasing trend, it is considered essential to take
some immediate measures.
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